Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	193.39	189.18	226.75	523.51	123.41	160.02
Short-Term Investments	317.66	412.33	685.48	669.12	625.28	437.35
Cash & Short-Term Investments	511.04	601.52	912.22	1,193	748.69	597.37
Cash Growth	-22.35%	-34.06%	-23.51%	59.29%	25.33%	113.56%
Receivables	11.05	8.52	36.46	3.77	2.03	2.13
Prepaid Expenses	59.85	29.83	47.55	20.41	18.58	14.32
Restricted Cash	-	-	-	-	-	2.7
Other Current Assets	-	-	2.1	-	-	-
Total Current Assets	581.94	639.86	998.33	1,217	769.3	616.52
Property, Plant & Equipment	138.3	246.67	148.14	161	100.11	55.06
Long-Term Investments	188.34	287.09	136.39	126.59	420.29	0.16
Other Long-Term Assets	16.69	17.39	18.12	15.73	4.76	4.59
Total Assets	925.28	1,191	1,301	1,520	1,294	676.32
Accounts Payable	13.26	14.59	7.45	5.15	9.65	10.46
Accrued Expenses	40.84	55.36	60.13	60.88	43.31	25.55
Current Portion of Leases	27.38	20.25	18.6	16.69	9.11	5.7
Current Unearned Revenue	12.25	20.66	22.14	43.84	63.76	22.54
Other Current Liabilities	-	-	6.89	-	-	-
Total Current Liabilities	93.73	110.85	115.21	126.55	125.83	64.25
Long-Term Leases	70.59	189.95	96.75	114.02	64.91	33.61
Long-Term Unearned Revenue	12.54	18.26	38.85	19.93	63.48	51.39
Other Long-Term Liabilities	-	-	-	24.03	-	-
Total Liabilities	176.85	319.06	250.81	284.53	254.22	149.25
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,242	3,049	2,711	2,420	1,746	962.17
Retained Earnings	-2,494	-2,177	-1,658	-1,177	-703	-435.11
Comprehensive Income & Other	0.99	0.61	-2.26	-7.46	-2.63	0
Total Common Equity	748.42	871.96	1,050	1,236	1,040	527.07
Shareholders' Equity	748.42	871.96	1,050	1,236	1,040	527.07
Total Liabilities & Equity	925.28	1,191	1,301	1,520	1,294	676.32
Total Debt	97.97	210.2	115.35	130.7	74.02	39.31
Net Cash (Debt)	571.89	651.53	896.74	1,131	1,012	558.07
Net Cash Growth	-32.16%	-27.34%	-20.73%	11.78%	81.34%	109.72%
Net Cash Per Share	5.45	6.59	10.10	14.70	14.28	9.97
Filing Date Shares Outstanding	115.83	103.52	96.11	88.02	74.67	67.73
Total Common Shares Outstanding	115.79	102.03	93	87.1	74.49	66.23
Working Capital	488.22	529.01	883.12	1,090	643.47	552.26
Book Value Per Share	6.46	8.55	11.29	14.19	13.97	7.96
Tangible Book Value	748.42	871.96	1,050	1,236	1,040	527.07
Tangible Book Value Per Share	6.46	8.55	11.29	14.19	13.97	7.96
Machinery	-	71.97	67.59	56.33	43.34	32.7
Leasehold Improvements	-	3.2	3.13	3.07	2.19	1.52

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q